Literature DB >> 9640249

The CD8+ granzyme B+ T-cell subset in peripheral blood from healthy individuals contains activated and apoptosis-prone cells.

P C Wever1, H J Van Der Vliet, L H Spaeny, A M Wolbink, F N Van Diepen, C J Froelich, C E Hack, I J ten Berge.   

Abstract

Granzyme B (GrB) has been implicated in induction of apoptosis in target cells. The presence of GrB in peripheral blood CD8+ T cells from healthy individuals was analysed in immunocytochemical and flow cytometric studies. Furthermore, CD8+ GrB- T cells and CD8+ GrB+ T cells were compared regarding phenotypical characteristics and susceptibility to both spontaneous and Fasmediated apoptosis. GrB was expressed by approximately one-fifth of CD8+ T cells. Compared with the CD8+ GrB- T-cell subset, the CD8+ GrB+ T-cell subset contained cells that were relatively more activated and more prone to spontaneous apoptosis. Culturing of cells with immunoglobulin M (IgM) anti-Fas monoclonal antibody had no additional effect on the number of CD8+ GrB+ T cells undergoing apoptosis. We suggest that the presence of CD8+ GrB+ T cells in peripheral blood from healthy individuals results from immune surveillance or contact with infectious agents, and that spontaneous apoptosis of these cells might serve as a mechanism for their eventual clearance.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9640249      PMCID: PMC1364087          DOI: 10.1046/j.1365-2567.1998.00448.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  34 in total

1.  Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood.

Authors:  T Miyawaki; T Uehara; R Nibu; T Tsuji; A Yachie; S Yonehara; N Taniguchi
Journal:  J Immunol       Date:  1992-12-01       Impact factor: 5.422

2.  Purification and characterization of cytolytic and noncytolytic human natural killer cell subsets.

Authors:  L T Lebow; B Bonavida
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

3.  Disruption of the internal thioester bond in the third component of complement (C3) results in the exposure of neodeterminants also present on activation products of C3. An analysis with monoclonal antibodies.

Authors:  C E Hack; J Paardekooper; R J Smeenk; J Abbink; A J Eerenberg; J H Nuijens
Journal:  J Immunol       Date:  1988-09-01       Impact factor: 5.422

Review 4.  Apoptosis.

Authors:  J J Cohen
Journal:  Immunol Today       Date:  1993-03

5.  DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement.

Authors:  L B Owen-Schaub; S Yonehara; W L Crump; E A Grimm
Journal:  Cell Immunol       Date:  1992-03       Impact factor: 4.868

6.  Requirements for CD28-dependent T cell-mediated cytotoxicity.

Authors:  M Azuma; M Cayabyab; J H Phillips; L L Lanier
Journal:  J Immunol       Date:  1993-03-15       Impact factor: 5.422

7.  CD28- T lymphocytes. Antigenic and functional properties.

Authors:  M Azuma; J H Phillips; L L Lanier
Journal:  J Immunol       Date:  1993-02-15       Impact factor: 5.422

8.  Expression of perforin and serine esterases by human gamma/delta T cells.

Authors:  H Koizumi; C C Liu; L M Zheng; S V Joag; N K Bayne; J Holoshitz; J D Young
Journal:  J Exp Med       Date:  1991-02-01       Impact factor: 14.307

9.  Perforin and serine esterase gene expression in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin A.

Authors:  C C Liu; S Rafii; A Granelli-Piperno; J A Trapani; J D Young
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

10.  The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory.

Authors:  A N Akbar; N Borthwick; M Salmon; W Gombert; M Bofill; N Shamsadeen; D Pilling; S Pett; J E Grundy; G Janossy
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

View more
  2 in total

1.  Effects of alpha-galactosylceramide (KRN7000), interleukin-12 and interleukin-7 on phenotype and cytokine profile of human Valpha24+ Vbeta11+ T cells.

Authors:  H J Van Der Vliet; N Nishi; Y Koezuka; M A Peyrat; B M Von Blomberg; A J Van Den Eertwegh; H M Pinedo; G Giaccone; R J Scheper
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

2.  Consensus nomenclature for CD8+ T cell phenotypes in cancer.

Authors:  Lionel Apetoh; Mark J Smyth; Charles G Drake; Jean-Pierre Abastado; Ron N Apte; Maha Ayyoub; Jean-Yves Blay; Marc Bonneville; Lisa H Butterfield; Anne Caignard; Chiara Castelli; Federica Cavallo; Esteban Celis; Lieping Chen; Mario P Colombo; Begoña Comin-Anduix; Georges Coukos; Madhav V Dhodapkar; Glenn Dranoff; Ian H Frazer; Wolf-Hervé Fridman; Dmitry I Gabrilovich; Eli Gilboa; Sacha Gnjatic; Dirk Jäger; Pawel Kalinski; Howard L Kaufman; Rolf Kiessling; John Kirkwood; Alexander Knuth; Roland Liblau; Michael T Lotze; Enrico Lugli; Francesco Marincola; Ignacio Melero; Cornelis J Melief; Thorsten R Mempel; Elizabeth A Mittendorf; Kunle Odun; Willem W Overwijk; Anna Karolina Palucka; Giorgio Parmiani; Antoni Ribas; Pedro Romero; Robert D Schreiber; Gerold Schuler; Pramod K Srivastava; Eric Tartour; Danila Valmori; Sjoerd H van der Burg; Pierre van der Bruggen; Benoît J van den Eynde; Ena Wang; Weiping Zou; Theresa L Whiteside; Daniel E Speiser; Drew M Pardoll; Nicholas P Restifo; Ana C Anderson
Journal:  Oncoimmunology       Date:  2015-02-25       Impact factor: 8.110

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.